enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. IP1867B - Wikipedia

   en.wikipedia.org/wiki/IP1867B

   IP1867B is a potential brain cancer treatment under development by Innovate Pharmaceuticals for use in the treatment of brain tumors, by combining reformulated aspirin with two additional ingredients, into a soluble form. [1] Developing a true liquid aspirin has long been a scientific goal.

3. Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock ... - AOL

   www.aol.com/why-nano-cap-cancer-focused...

   On Wednesday, AbbVie Inc (NYSE:ABBV) and Xilio Therapeutics, Inc. (NASDAQ:XLO) announced a collaboration and option-to-license agreement to develop novel tumor-activated, antibody-based ...

4. mRNA-4157/V940 - Wikipedia

   en.wikipedia.org/wiki/MRNA-4157/V940

   mRNA-4157/V940 is an mRNA based cancer vaccine.When administered, it will produce one of several dozen possible abnormal proteins commonly found in cancerous tissues. The production of those proteins is intended to invoke an immune response.

5. List of drugs granted breakthrough therapy designation

   en.wikipedia.org/wiki/List_of_drugs_granted...

   Treatment of generalized pustular psoriasis (GPP) in people aged twelve years of age and older and weighing at least 40 kg [2] Tarlatamab: Treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy [2] Tirzepatide: Eli Lilly

6. ‘World-first trial could revolutionise brain cancer treatment ...

   www.aol.com/world-first-trial-could...

   The research will trial multiple new treatments for people in the UK living with glioblastoma.

7. What's Going On With Mid-Cap Cancer-Focused Verastem ... - AOL

   www.aol.com/whats-going-mid-cap-cancer-144521157...

   Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 trial evaluating avutometinib plus defactinib in combination ...

8. Hospitals begin offering breakthrough radiation therapy for ...

   www.aol.com/news/hospitals-begin-offering...

   For premium support please call: 800-290-4726 more ways to reach us

9. Imatinib - Wikipedia

   en.wikipedia.org/wiki/Imatinib

   A formulation of imatinib with a cyclodextrin (Captisol) as a carrier to overcome the blood–brain barrier has shown reversal of opioid tolerance in a 2012 study in rats. [97] Imatinib is an experimental drug in the treatment of desmoid tumor or aggressive fibromatosis. [98]